Research Article
[Retracted] NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641
Table 1
Correlation between the expression level of NR2F1-AS1 and clinical characteristics of BC patients (n = 54).
| Clinical characteristics | Number of cases (n = 54) | NR2F1-AS1 expression | Low (n = 25) | High (n = 29) | value |
| Age (years) | | | | 0.510 | ≥50 | 32 | 16 | 16 | | <50 | 22 | 9 | 13 | | Tumor size | | | | 0.300 | ≥2 cm | 24 | 13 | 11 | | <2 cm | 30 | 12 | 18 | | Lymph node metastasis | | | | 0.003 | Absent | 36 | 22 | 14 | | Present | 18 | 3 | 15 | | ER status | | | | 0.419 | Negative | 26 | 12 | 14 | | Positive | 28 | 16 | 12 | | TNM stage | | | | 0.028 | I-II | 42 | 23 | 21 | | III | 12 | 2 | 10 | |
|
|
, the difference is significant; , the difference is highly significant. |